stella
beta
Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure — Stella
Recruiting
Back to HCC - Hepatocellular Carcinoma trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Trial locations
(1 site)
France
Hospitl Avicenne, Bobigny
View full record on ClinicalTrials.gov